文献速递肿瘤 PET/CT核素与放射性配体治疗

PSMA PET/CT的SUVmax与术中Drop-In γ探针信号在前列腺癌病灶识别中的强相关性

Strong Correlation Between SUVmax on PSMA PET/CT and Numeric Drop-In γ-Probe Signal for Intraoperative Identification of Prostate Cancer Lesions.
PubMed 文献 · J Nucl Med · 2024-04-01

基于前瞻性单臂单中心可行性研究(NCT03857113)的二次分析,纳入29例生化复发且盆腔最多3个可疑病灶的前列腺癌患者,术前注射99mTc-PSMA-I&S后使用Drop-In γ探针行放射引导手术。33个PET可见病灶中31个被切除,病灶SUVmax与术中计数率呈强正相关(体内ρs=0.728,体外ρs=0.763,P<0.001)。结论认为SUVmax与探针读数直接相关,可用于筛选PSMA放射引导手术患者,但需进一步研究验证。

要点

  • PSMA PET/CT病灶SUVmax与Drop-In γ探针术中计数率呈强正相关(体内ρs=0.728,体外ρs=0.763,P<0.001)。
  • SUVmax≥6亚组体内信号与SUVmax显著正相关(ρs=0.774,P<0.001),SUVmax<6亚组无统计学显著相关(ρs=0.382,P=0.221)。
  • 作者认为SUVmax可用于筛选适合PSMA放射引导手术的患者,但需进一步研究验证。

核心结论

  • PSMA PET/CT的SUVmax与手术Drop-In探针记录的读数之间存在直接关系,表明SUVmax可用于筛选适合PSMA放射引导手术的患者。
  • 为制定更明确的亚组定义以指导治疗推荐,需进一步研究验证本研究发现。

研究设计与样本

  • 基于前瞻性、单臂、单中心可行性研究(NCT03857113)的二次分析。
  • 纳入29例既往根治性治疗后生化复发、术前PSMA PET/CT显示盆腔内最多3个可疑病灶的患者。
  • 排除术前6个月内接受雄激素剥夺治疗的患者。
  • 所有患者术前1天静脉注射99mTc-PSMA-I&S,使用Drop-In γ探针实现放射引导。
  • 采用Spearman秩相关系数(ρs)分析相关性,亚组分析基于SUVmax中位数。

主要发现

  • PSMA PET/CT共显示33个病灶,总体SUVmax中位数为6.2(四分位距4.2-9.7)。
  • 放射引导手术切除31个病灶。
  • Drop-In计数率中位数体内为134(四分位距81-220),体外为109(四分位距72-219)。
  • 病灶SUVmax与探针计数率强度相关:体内ρs=0.728,体外ρs=0.763(均P<0.001)。
  • SUVmax<6亚组:体内信号与SUVmax无统计学显著相关(ρs=0.382,P=0.221),信号本底比亦无统计学显著相关(ρs=0.245,P=0.442);SUVmax≥6亚组:体内信号ρs=0.774(P<0.001),信号本底比ρs=0.647(P=0.007),均呈统计学显著正相关。

关键数值与推荐

  • PSMA PET/CT病灶总体SUVmax中位数6.2(四分位距4.2-9.7)。
  • Drop-In计数率中位数体内134(四分位距81-220),体外109(四分位距72-219)。
  • SUVmax与探针计数率相关性:体内ρs=0.728(P<0.001),体外ρs=0.763(P<0.001)。
  • SUVmax<6亚组体内信号ρs=0.382(P=0.221),信号本底比ρs=0.245(P=0.442)。
  • SUVmax≥6亚组体内信号ρs=0.774(P<0.001),信号本底比ρs=0.647(P=0.007)。

临床怎么用

  • 作者认为SUVmax与Drop-In探针读数直接相关,可用于筛选适合PSMA放射引导手术的患者。
  • 作者指出需进一步研究验证本研究发现,以制定更明确的亚组定义用于治疗推荐。

局限性

  • 原文为前瞻性、单臂、单中心可行性研究的二次分析。
  • 样本量为29例患者、33个病灶,其中放射引导手术切除31个病灶。
  • 作者指出需进一步研究验证本研究发现,以制定更明确的亚组定义用于治疗推荐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Prostate-specific membrane antigen (PSMA) PET is used to select patients with recurrent prostate cancer for metastasis-directed therapy. A surgical approach can be achieved through radioguided surgery (RGS), using a Drop-In γ-probe that traces lesions that accumulate the radioactive signal. With the aim of guiding patient selection for salvage surgery, we studied the correlation between the SUVmax of lesions on preoperative PSMA PET/CT and their intraoperative counts/s measured using the Drop-In γ-probe. Methods: A secondary analysis based on the prospective, single-arm, and single-center feasibility study was conducted (NCT03857113). Patients (n = 29) with biochemical recurrence after previous curative-intent therapy and a maximum of 3 suggestive lesions within the pelvis on preoperative PSMA PET/CT were included. Patients treated with androgen deprivation therapy within 6 mo before surgery were excluded. All patients received an intravenous injection of 99mTc-PSMA-I&S 1 d before surgery. Radioguidance was achieved using a Drop-In γ-probe. Correlation was determined using the Spearman rank correlation coefficient (ρs). Subgroup analysis was based on the median SUVmax Results: In total, 33 lesions were visible on the PSMA PET/CT images, with a median overall SUVmax of 6.2 (interquartile range [IQR], 4.2-9.7). RGS facilitated removal of 31 lesions. The median Drop-In counts/s were 134 (IQR, 81-220) in vivo and 109 (IQR, 72-219) ex vivo. The intensity of the values correlated with SUVmax (ρs = 0.728 and 0.763, respectively; P < 0.001). Subgroup analysis based on median SUVmax in the group with an SUVmax of less than 6 showed no statistically significant correlation with the numeric signal in vivo (ρs = 0.382; P = 0.221) or the signal-to-background-ratio (ρs = 0.245; P = 0.442), whereas the group with an SUVmax of 6 or more showed respective statistically significant positive correlations (ρs = 0.774 [P < 0.001] and ρs = 0.647 [P = 0.007]). Conclusion: Our findings indicate that there is a direct relation between SUVmax on PSMA PET/CT and the readout recorded by the surgical Drop-In probe, thereby indicating that SUVmax can be used to select patients for PSMA RGS. For more definitive subgroup definitions for treatment recommendations, further studies are necessary to validate the present findings.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Berrens AC, Sorbi MA, Donswijk ML, et al. Strong Correlation Between SUVmax on PSMA PET/CT and Numeric Drop-In γ-Probe Signal for Intraoperative Identification of Prostate Cancer Lesions. J Nucl Med. 2024. PMID: 38485277. doi:10.2967/jnumed.123.267075

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。